Compare UNTY & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNTY | CTKB |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.4M | 433.8M |
| IPO Year | 1997 | 2021 |
| Metric | UNTY | CTKB |
|---|---|---|
| Price | $56.14 | $4.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $59.67 | $5.88 |
| AVG Volume (30 Days) | 37.5K | ★ 1.3M |
| Earning Date | 01-14-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ 35.12 | N/A |
| EPS | ★ 5.27 | N/A |
| Revenue | $121,970,000.00 | ★ $196,828,000.00 |
| Revenue This Year | $24.41 | N/A |
| Revenue Next Year | $11.16 | $5.62 |
| P/E Ratio | $10.69 | ★ N/A |
| Revenue Growth | ★ 20.98 | N/A |
| 52 Week Low | $36.65 | $2.37 |
| 52 Week High | $57.24 | $7.30 |
| Indicator | UNTY | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 75.28 | 46.59 |
| Support Level | $55.35 | $4.56 |
| Resistance Level | $57.24 | $5.16 |
| Average True Range (ATR) | 1.76 | 0.24 |
| MACD | 0.33 | -0.09 |
| Stochastic Oscillator | 86.16 | 25.24 |
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.